Viewing Study NCT03954132


Ignite Creation Date: 2025-12-24 @ 9:39 PM
Ignite Modification Date: 2025-12-25 @ 7:21 PM
Study NCT ID: NCT03954132
Status: COMPLETED
Last Update Posted: 2024-04-24
First Post: 2019-05-15
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Spiolto® Respimat® (Tiotropium/Olodaterol) Versus Triple Combination Therapy in Everyday Clinical Treatment Practice for Chronic Obstructive Pulmonary Disease (EVELUT®)
Sponsor: Boehringer Ingelheim
Organization: